Firm
The firm is continuing its aggressive IP hiring streak with the addition of partner Matthew Rizzolo
New partners, including the firm’s first female head of a department, are eyeing a deeper focus on client understanding
Essenese Obhan shares his expansion plans and vision of creating a ‘one-stop shop’ for clients after Indian firms Obhan & Associates and Mason & Associates joined forces
From AI and the UPC to troublesome trademarks in China, experts name the IP trends likely to dominate 2026
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Liu, Shen & AssociatesWenjing Zhu of Liu, Shen & Associates explains how China’s administrative adjudication system is reshaping patent enforcement, offering faster, cost-effective, and technically expert resolutions for patentees, while preserving rights to pursue court remedies -
Sponsored by Wanhuida Intellectual PropertyMinnan (Miranda) Xie of Wanhuida Intellectual Property analyses how China’s patent authorities and courts assess second medical use inventions, with key CNIPA decisions clarifying the treatment of dosage regimens and patient subgroups in novelty determinations
-
Sponsored by InventaVítor Palmela Fidalgo of Inventa examines how Portuguese case law diverges from EU rules on acquired distinctiveness, highlighting the Pão de Rio Maior decision and its implications for trademark interpretation and consumer protection
-
Sponsored by Tilleke & GibbinsVietnam’s boom in AI-generated songs raises fundamental copyright questions, say Linh Duy Mai and Diep Thi Bich Le of T&G Law Firm LLC (TGVN), the local associate of Tilleke & Gibbins
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law explains why the ruling by South Korea’s Intellectual Property High Court marks a key development in online patent enforcement
-
Sponsored by Becerril, Coca & BecerrilCarlos Hernández León of Becerril, Coca & Becerril outlines how Mexico’s shift from NAFTA-based patent term extensions to the new SPC regime affects patent holders, particularly in pharmaceuticals, and the strategic steps to secure additional protection
